Vir Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,331	1,353	3,369	5,480	3,411	1,379
Market Cap Growth	-55.98%	-59.83%	-38.52%	60.63%	147.35%	-
Enterprise Value	311	-71	1,078	4,897	2,733	990
PE Ratio	-	-2.20	6.53	10.37	-11.42	-7.90
PS Ratio	17.14	15.70	2.09	5.00	44.67	170.46
PB Ratio	0.88	0.85	1.62	3.83	4.76	3.25
P/FCF Ratio	-1.76	-1.69	2.11	-78.96	-17.27	-9.95
P/OCF Ratio	-1.79	-1.74	2.03	-115.15	-17.87	-10.64
EV/Sales Ratio	3.90	-0.82	0.67	4.47	35.79	122.31
EV/EBITDA Ratio	-0.60	0.12	1.40	8.72	-9.43	-5.82
EV/EBIT Ratio	-0.57	0.11	1.43	8.91	-9.15	-5.67
EV/FCF Ratio	-0.40	0.09	0.68	-70.55	-13.84	-7.14
Debt / Equity Ratio	0.07	0.07	0.06	0.09	0.09	-
Debt / EBITDA Ratio	-0.21	-0.19	0.16	0.24	-0.23	-
Debt / FCF Ratio	-0.14	-0.14	0.08	-1.92	-0.34	-
Quick Ratio	12.36	8.75	4.73	4.37	7.52	6.58
Current Ratio	12.90	9.06	4.93	4.58	7.80	6.81
Asset Turnover	0.04	0.04	0.59	0.82	0.10	0.02
Return on Equity (ROE)	-32.60%	-34.90%	25.20%	57.20%	-48.30%	-142.70%
Return on Assets (ROA)	-27.00%	-27.70%	18.80%	39.50%	-39.70%	-49.60%
Return on Capital (ROIC)	-37.49%	-40.21%	25.88%	25.84%	-37.91%	-41.98%
Earnings Yield	-39.53%	-45.45%	15.31%	9.65%	-8.75%	-12.67%
FCF Yield	-57.04%	-59.14%	47.35%	-1.27%	-5.79%	-10.05%
Buyback Yield / Dilution	-1.29%	0.50%	-1.03%	-11.98%	-292.62%	-295.88%
Total Shareholder Return	-1.29%	0.50%	-1.03%	-11.98%	-292.62%	-295.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).